Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population

Interventional Study at the Primary and Secondary Levels of Prevention for Knowledge Regarding GC Risk Factors in EU and CELAC Populations

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04019808

Acronym

LEGACY-3

Enrollment

800

Registered

2019-07-15

Start date

2019-07-30

Completion date

2023-12-31

Last updated

2024-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Keywords

Gastric Cancer, Personalized medicine, Oncology, Solid tumor, Primary Intervention

Brief summary

This study is divided into two parts: Part 1: An interventional study, with a pre-post study design to determinate the grade of knowledge of established GC risk factors. Part 2: An observational study to know impact on prevalence and infection eradication of H. pylori

Detailed description

Part 1: to determinate the grade of knowledge of established GC risk factors and identification of attitudes about, GC screening programs at baseline, prior to the intervention though an educational program. Part 2: to generate an H. pylori registry, to know its impact on prevalence and infection eradication rate at 6th, 12th, 24th and at Month 36th.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Inclusion criteria

Part A: Educational Intervention Inclusion criteria * Subjects \>18 years old, from EU and CELAC countries participating in this study. * Has given and signed the IC to participate in this study.

Exclusion criteria

* Subjects who have received some prior preparation (Cancer Gastric Information). * Subjects who have previous Knowledge in Gastric Cancer (Example, near relatives who have suffered Gastric Cancer Part B: H. pylori Register Inclusion criteria * Subjects ≥18 years old diagnose from H. pylori infection and treated at participant sites * Has given and signed the IC.

Design outcomes

Primary

Measure	Time frame	Description
knowledge GC risk factors and symptoms	3 years	Compare the results obtained through a knowledge of CG risk factors by study-specific questionnaire before and after an educational intervention
H. pylori prevalence and drug resistance	3 years	Generate an H. pylori registry, to know its impact on prevalence and infection eradication rate at months 6th, 12th, 24th and 36th.

Countries

Argentina, Chile, Mexico, Netherlands, Paraguay, Portugal, Spain

Outcome results